UniProt ID | V2R_HUMAN | |
---|---|---|
UniProt AC | P30518 | |
Protein Name | Vasopressin V2 receptor | |
Gene Name | AVPR2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 371 | |
Subcellular Localization |
Cell membrane Multi-pass membrane protein . |
|
Protein Description | Receptor for arginine vasopressin. The activity of this receptor is mediated by G proteins which activate adenylate cyclase. Involved in renal water reabsorption.. | |
Protein Sequence | MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
22 | N-linked_Glycosylation | SLPSLPSNSSQERPL CCCCCCCCCCCCCCC | 43.68 | UniProtKB CARBOHYD | |
117 | Phosphorylation | ALCRAVKYLQMVGMY HHHHHHHHHHHHHHH | 8.79 | 22817900 | |
124 | Phosphorylation | YLQMVGMYASSYMIL HHHHHHHHHCHHHHH | 9.45 | - | |
126 | Phosphorylation | QMVGMYASSYMILAM HHHHHHHCHHHHHHH | 12.43 | 26503892 | |
128 | Phosphorylation | VGMYASSYMILAMTL HHHHHCHHHHHHHHH | 5.91 | 26503892 | |
255 | Phosphorylation | RRGRRTGSPGEGAHV CCCCCCCCCCCCHHH | 29.17 | 28857561 | |
325 | Phosphorylation | SCTNPWIYASFSSSV CCCCHHHHHHCCCCC | 7.73 | 12436935 | |
341 | S-palmitoylation | SELRSLLCCARGRTP HHHHHHHHHHCCCCC | 1.75 | 12900404 | |
342 | S-palmitoylation | ELRSLLCCARGRTPP HHHHHHHHHCCCCCC | 2.67 | 12900404 | |
362 | Phosphorylation | DESCTTASSSLAKDT CCCCCCCCHHHHCCC | 20.54 | 9482866 | |
363 | Phosphorylation | ESCTTASSSLAKDTS CCCCCCCHHHHCCCC | 27.23 | 9482866 | |
364 | Phosphorylation | SCTTASSSLAKDTSS CCCCCCHHHHCCCCC | 29.83 | 9482866 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
255 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
255 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
362 | S | Phosphorylation | Kinase | GRK-SUBFAMILY | - | GPS |
363 | S | Phosphorylation | Kinase | GRK-SUBFAMILY | - | GPS |
364 | S | Phosphorylation | Kinase | GRK-SUBFAMILY | - | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of V2R_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of V2R_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MK03_HUMAN | MAPK3 | physical | 12473660 | |
ARRB2_HUMAN | ARRB2 | physical | 12473660 | |
C1QT1_HUMAN | C1QTNF1 | physical | 12409230 | |
TERA_HUMAN | VCP | physical | 18048502 | |
DERL1_HUMAN | DERL1 | physical | 18048502 | |
CHIP_HUMAN | STUB1 | physical | 20974815 | |
GBB1_HUMAN | GNB1 | physical | 15782186 | |
GBG2_HUMAN | GNG2 | physical | 15782186 | |
GNAS3_HUMAN | GNAS | physical | 15782186 | |
GNAS2_HUMAN | GNAS | physical | 15782186 | |
ALEX_HUMAN | GNAS | physical | 15782186 | |
GNAS1_HUMAN | GNAS | physical | 15782186 | |
ARRD4_HUMAN | ARRDC4 | physical | 23236378 | |
HGS_HUMAN | HGS | physical | 23236378 | |
CLH1_HUMAN | CLTC | physical | 23236378 | |
V2R_HUMAN | AVPR2 | physical | 10644689 | |
NEU2_HUMAN | AVP | physical | 10644689 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00252 | Congenital nephrogenic diabetes insipidus (NDI) | |||||
H01294 | Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) | |||||
OMIM Disease | ||||||
300539 | Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) | |||||
304800 | Diabetes insipidus, nephrogenic, X-linked (XNDI) | |||||
Kegg Drug | ||||||
D00101 | Vasopressin (JP16/USP); Pitressin (TN) | |||||
D00291 | Desmopressin (INN) | |||||
D00366 | Lypressin (USP/INN); Diapid (TN) | |||||
D01213 | Tolvaptan (JAN/USAN/INN); Samsca (TN) | |||||
D01236 | Conivaptan hydrochloride (JAN/USAN); Vaprisol (TN) | |||||
D01855 | Mozavaptane hydrochloride (JAN) | |||||
D02235 | Desmopressin acetate hydrate (JAN); Desmopressin acetate (USAN); Desmopressin acetate trihydrate; DD | |||||
D02983 | Argipressin tannate (USAN); Pitressin tannate (TN) | |||||
D04752 | Lixivaptan (USAN/INN) | |||||
D06672 | Terlipressin (USAN/INN); Lucassin (TN) | |||||
D07227 | Ornipressin (INN); POR 8 Sandoz (TN) | |||||
D07748 | Conivaptan (INN) | |||||
D08571 | Terlipressin acetate (JAN); Heamopressin (TN) | |||||
D09820 | Vasopressin tannate (JAN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...